Prevention of poliomyelitis: Recommendations for use of only inactivated poliovirus vaccine for routine immunization

J. S. Abramson, C. J. Baker, M. C. Fisher, M. A. Gerber, H. C. Meissner, Dennis L Murray, G. D. Overturf, C. G. Prober, M. B. Rennels, T. N. Saari, L. B. Weiner, R. J. Whitley

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Since 1997, when the American Academy of Pediatrics (AAP) initially recommended expanded use of inactivated poliovirus vaccine (IPV) for routine childhood immunization against poliovirus infection, the occurrence of vaccine-associated paralytic poliomyelitis (VAPP) has decreased in the United States. However, VAPP will not be eliminated until oral poliovirus vaccine (OPV) no longer is given. As a result of continuing progress toward global eradication of poliomyelitis, the risk of imported infection has continued to decrease. Concomitantly, the use of IPV has increased substantially with the corresponding decrease in the use of OPV, indicating widespread acceptance by health care professionals and parents of the sequential or all-IPV immunization schedule previously recommended by the AAP. In addition, availability of OPV will be substantially diminished beginning in early 2000. To eliminate VAPP in the context of decreasing risk of wild-type poliovirus importation, the AAP recommends an all-IPV schedule for routine childhood immunization beginning in early 2000. The AAP further recommends that, effective immediately, OPV no longer should be purchased for routine use. Guidelines are given for utilization of remaining supplies of OPV during the transition in early 2000 to the all-IPV schedule.

Original languageEnglish (US)
Pages (from-to)1404-1406
Number of pages3
JournalPediatrics
Volume104
Issue number6
DOIs
StatePublished - Dec 1 1999

Fingerprint

Inactivated Poliovirus Vaccine
Oral Poliovirus Vaccine
Poliomyelitis
Immunization
Pediatrics
Poliovirus
Vaccines
Appointments and Schedules
Immunization Schedule
Infection
Guidelines
Delivery of Health Care

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Abramson, J. S., Baker, C. J., Fisher, M. C., Gerber, M. A., Meissner, H. C., Murray, D. L., ... Whitley, R. J. (1999). Prevention of poliomyelitis: Recommendations for use of only inactivated poliovirus vaccine for routine immunization. Pediatrics, 104(6), 1404-1406. https://doi.org/10.1542/peds.104.6.1404

Prevention of poliomyelitis : Recommendations for use of only inactivated poliovirus vaccine for routine immunization. / Abramson, J. S.; Baker, C. J.; Fisher, M. C.; Gerber, M. A.; Meissner, H. C.; Murray, Dennis L; Overturf, G. D.; Prober, C. G.; Rennels, M. B.; Saari, T. N.; Weiner, L. B.; Whitley, R. J.

In: Pediatrics, Vol. 104, No. 6, 01.12.1999, p. 1404-1406.

Research output: Contribution to journalArticle

Abramson, JS, Baker, CJ, Fisher, MC, Gerber, MA, Meissner, HC, Murray, DL, Overturf, GD, Prober, CG, Rennels, MB, Saari, TN, Weiner, LB & Whitley, RJ 1999, 'Prevention of poliomyelitis: Recommendations for use of only inactivated poliovirus vaccine for routine immunization', Pediatrics, vol. 104, no. 6, pp. 1404-1406. https://doi.org/10.1542/peds.104.6.1404
Abramson, J. S. ; Baker, C. J. ; Fisher, M. C. ; Gerber, M. A. ; Meissner, H. C. ; Murray, Dennis L ; Overturf, G. D. ; Prober, C. G. ; Rennels, M. B. ; Saari, T. N. ; Weiner, L. B. ; Whitley, R. J. / Prevention of poliomyelitis : Recommendations for use of only inactivated poliovirus vaccine for routine immunization. In: Pediatrics. 1999 ; Vol. 104, No. 6. pp. 1404-1406.
@article{56654b23f13544f38efda0e833bbe7e7,
title = "Prevention of poliomyelitis: Recommendations for use of only inactivated poliovirus vaccine for routine immunization",
abstract = "Since 1997, when the American Academy of Pediatrics (AAP) initially recommended expanded use of inactivated poliovirus vaccine (IPV) for routine childhood immunization against poliovirus infection, the occurrence of vaccine-associated paralytic poliomyelitis (VAPP) has decreased in the United States. However, VAPP will not be eliminated until oral poliovirus vaccine (OPV) no longer is given. As a result of continuing progress toward global eradication of poliomyelitis, the risk of imported infection has continued to decrease. Concomitantly, the use of IPV has increased substantially with the corresponding decrease in the use of OPV, indicating widespread acceptance by health care professionals and parents of the sequential or all-IPV immunization schedule previously recommended by the AAP. In addition, availability of OPV will be substantially diminished beginning in early 2000. To eliminate VAPP in the context of decreasing risk of wild-type poliovirus importation, the AAP recommends an all-IPV schedule for routine childhood immunization beginning in early 2000. The AAP further recommends that, effective immediately, OPV no longer should be purchased for routine use. Guidelines are given for utilization of remaining supplies of OPV during the transition in early 2000 to the all-IPV schedule.",
author = "Abramson, {J. S.} and Baker, {C. J.} and Fisher, {M. C.} and Gerber, {M. A.} and Meissner, {H. C.} and Murray, {Dennis L} and Overturf, {G. D.} and Prober, {C. G.} and Rennels, {M. B.} and Saari, {T. N.} and Weiner, {L. B.} and Whitley, {R. J.}",
year = "1999",
month = "12",
day = "1",
doi = "10.1542/peds.104.6.1404",
language = "English (US)",
volume = "104",
pages = "1404--1406",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "6",

}

TY - JOUR

T1 - Prevention of poliomyelitis

T2 - Recommendations for use of only inactivated poliovirus vaccine for routine immunization

AU - Abramson, J. S.

AU - Baker, C. J.

AU - Fisher, M. C.

AU - Gerber, M. A.

AU - Meissner, H. C.

AU - Murray, Dennis L

AU - Overturf, G. D.

AU - Prober, C. G.

AU - Rennels, M. B.

AU - Saari, T. N.

AU - Weiner, L. B.

AU - Whitley, R. J.

PY - 1999/12/1

Y1 - 1999/12/1

N2 - Since 1997, when the American Academy of Pediatrics (AAP) initially recommended expanded use of inactivated poliovirus vaccine (IPV) for routine childhood immunization against poliovirus infection, the occurrence of vaccine-associated paralytic poliomyelitis (VAPP) has decreased in the United States. However, VAPP will not be eliminated until oral poliovirus vaccine (OPV) no longer is given. As a result of continuing progress toward global eradication of poliomyelitis, the risk of imported infection has continued to decrease. Concomitantly, the use of IPV has increased substantially with the corresponding decrease in the use of OPV, indicating widespread acceptance by health care professionals and parents of the sequential or all-IPV immunization schedule previously recommended by the AAP. In addition, availability of OPV will be substantially diminished beginning in early 2000. To eliminate VAPP in the context of decreasing risk of wild-type poliovirus importation, the AAP recommends an all-IPV schedule for routine childhood immunization beginning in early 2000. The AAP further recommends that, effective immediately, OPV no longer should be purchased for routine use. Guidelines are given for utilization of remaining supplies of OPV during the transition in early 2000 to the all-IPV schedule.

AB - Since 1997, when the American Academy of Pediatrics (AAP) initially recommended expanded use of inactivated poliovirus vaccine (IPV) for routine childhood immunization against poliovirus infection, the occurrence of vaccine-associated paralytic poliomyelitis (VAPP) has decreased in the United States. However, VAPP will not be eliminated until oral poliovirus vaccine (OPV) no longer is given. As a result of continuing progress toward global eradication of poliomyelitis, the risk of imported infection has continued to decrease. Concomitantly, the use of IPV has increased substantially with the corresponding decrease in the use of OPV, indicating widespread acceptance by health care professionals and parents of the sequential or all-IPV immunization schedule previously recommended by the AAP. In addition, availability of OPV will be substantially diminished beginning in early 2000. To eliminate VAPP in the context of decreasing risk of wild-type poliovirus importation, the AAP recommends an all-IPV schedule for routine childhood immunization beginning in early 2000. The AAP further recommends that, effective immediately, OPV no longer should be purchased for routine use. Guidelines are given for utilization of remaining supplies of OPV during the transition in early 2000 to the all-IPV schedule.

UR - http://www.scopus.com/inward/record.url?scp=0032754481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032754481&partnerID=8YFLogxK

U2 - 10.1542/peds.104.6.1404

DO - 10.1542/peds.104.6.1404

M3 - Article

C2 - 10585998

AN - SCOPUS:0032754481

VL - 104

SP - 1404

EP - 1406

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 6

ER -